Predictive Oncology Q2 net loss $3.9M on revenue $490K; cash burn $7M in H1 2023

Axe Compute Inc.

Net loss of $3.9M ($0.98 per share) vs $2.89 loss per share in Q2 2022.
Revenue rose 32% to $490,110 from $371,591; gross margin improved to 67% from 64%.
Cash and equivalents $14.8M, down from $22.1M at Dec 31, 2022; equity $14.7M.
G&A expenses increased by $353K to $2.7M; sales & marketing up $158K to $429K.
Business updates: collaborations with CRH and Cvergenx, new board members, HQ moved to Pittsburgh.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Axe Compute Inc. reported three months ended June 30, 2023 results: revenue $0.5 million, net income a net loss of $3.9 million, EPS $0.98 loss per common share.

Period: three months ended June 30, 2023
Revenue: $0.5 million
Net income: a net loss of $3.9 million
EPS: $0.98 loss per common share
Result: reported results

Exact text from the filing

The company reported a net loss of $3.9 million on total net revenue of $0.5 million for the second quarter 2023.

View on SEC.gov

16 earnings releases filed in the last 30 days. Browse all earnings releases →

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-23-005235

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.